Combining neuroscience, advanced engineering and manufacturing
Our capabilities drive the development of technologies and devices that can access and directly interface with the human brain. The aim is to either record brain signals for improved communication or movement control through intelligent prostheses and/or modulate the brain’s activity via electrical, optical or biological means for therapy.
Our development efforts depend on close collaborations with clinical and academic leaders in the field of neuroscience and neurosurgery and take place within the strict ethical and regulatory frameworks in Switzerland, the EU and the US.
Key focus areas in neurotechnology development
The Wyss Center’s development efforts begin at the idea generation stage and continue with prototype fabrication and on to product development and clinical validation.
We develop innovative medical grade technologies that interface with the nervous system such as brain-machine interfaces, neuromonitoring and neurostimulation devices to understand, repair or replace nervous system function. Leading indications include epilepsy, Parkinson’s disease, ALS, spinal cord injury and stroke.
Our work spans the following aspects of development:
Concept - Conceptualization of innovative technologies that interface with the nervous system
Feasibility studies - Readiness screening and technical, clinical and business feasibility assessments including business model development and reimbursement scenarios
Prototype development - Design and prototyping of hardware and software subsystems and their integration
Validation - Testing, analysis, modeling and optimization in the laboratory and the clinic
Quality assurance - Providing confidence that all quality requirements are fulfilled according to European and US standards, technical documentation generation and review
Regulatory strategy and submission - Development of regulatory strategies as a technology is developed, technical documentation generation and review according to applicable EU and US standards and regulations
Clinical trials - Clinical trials protocol design and submission, collaboration with clinical groups for first-in-human studies
Commercialization - Licensing of technologies developed at the Wyss Center to commercial entities for the benefit of humankind
2nd EPFL-Wyss Center call for entrepreneurial projects
Are you developing a promising technology in the field of applied neuroscience or neurotechnology? Do you intend to bring it to the market? This joint EPFL-Wyss Center call for projects might be for you.Collaboration
Wyss Center joins Wellcome Leap global network dedicated to accelerated breakthroughs in human health
Charter group of 21 world-class institutions representing a network of over 150,000 researchers across six continents sign agreement that sets new bar for fast-paced research and development.Collaboration
A weather station for epilepsy
Epilepsy forecasts could help people manage their daily life and medication around their chance of seizures.Collaboration